[18F]FDG PET/CT for predicting triple-negative breast cancer outcomes after neoadjuvant chemotherapy with or without pembrolizumab

被引：0
|
作者：
Romain-David Seban
Emilie Arnaud
Delphine Loirat
Luc Cabel
Paul Cottu
Lounes Djerroudi
Segolene Hescot
Pierre Loap
Claire Bonneau
Francois-Clement Bidard
Virginie Huchet
Nina Jehanno
Arnaud Berenbaum
Laurence Champion
Irene Buvat
机构：
[1] Department of Nuclear Medicine and Endocrine Oncology,Laboratoire d’Imagerie Translationnelle en Oncologie, Inserm U1288, Institut Curie
[2] Institut Curie,Department of Medical Oncology, Institut Curie
[3] PSL University,Department of Medical Oncology, Institut Curie
[4] Paris Saclay University,Circulating Tumor Biomarkers Laboratory, Institut Curie
[5] PSL Research University,undefined
[6] Department of Pathology,undefined
[7] Institut Curie,undefined
[8] Department of Radiation Oncology,undefined
[9] Institut Curie,undefined
[10] Inserm U900,undefined
[11] Institut Curie,undefined
[12] Department of Surgery,undefined
[13] Institut Curie,undefined
[14] UVSQ/Paris-Saclay University,undefined
[15] SiRIC,undefined
[16] PSL Research University,undefined
[17] Department of Nuclear Medicine,undefined
[18] Institut Curie,undefined
来源：
European Journal of Nuclear Medicine and Molecular Imaging | 2023年 / 50卷
关键词：
Early triple-negative breast cancer; Neoadjuvant chemotherapy ± pembrolizumab; Pathologic response; [18F]FDG PET/CT; Tumor metabolism; Metabolic tumor burden;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：4024 / 4035
页数：11
相关论文
共 50 条
  • [1] [18F]FDG PET/CT for predicting triple-negative breast cancer outcomes after neoadjuvant chemotherapy with or without pembrolizumab
    Seban, Romain-David
    Arnaud, Emilie
    Loirat, Delphine
    Cabel, Luc
    Cottu, Paul
    Djerroudi, Lounes
    Hescot, Segolene
    Loap, Pierre
    Bonneau, Claire
    Bidard, Francois-Clement
    Huchet, Virginie
    Jehanno, Nina
    Berenbaum, Arnaud
    Champion, Laurence
    Buvat, Irene
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2023, 50 (13) : 4024 - 4035
  • [2] Clinical utility of [18F]FDG PET/CT in triple-negative breast cancer patients treated with neoadjuvant chemotherapy with or without immunotherapy
    Seban, R.
    Arnaud, E.
    Loirat, D.
    Cabel, L.
    Cottu, P.
    Djerroudi, L.
    Hescot, S.
    Loap, P.
    Bonneau, C.
    Bidard, F.
    Huchet, V.
    Jehanno, N.
    Berenbaum, A.
    Champion, L.
    Buvat, I.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2023, 50 (SUPPL 1) : S33 - S33
  • [3] The prognostic role of baseline and post neoadjuvant chemotherapy [18F]FDG PET/CT in triple-negative breast cancer: preliminary results of the TRINE-PET trial
    Urso, L.
    Evangelista, L.
    Albano, D.
    Filippi, L.
    Panareo, S.
    Taralli, S.
    Mazzoletti, A.
    Annovazzi, A.
    Fantini, L.
    Mangia, M.
    Sofia, L.
    Setti, L.
    Bianchi, A.
    Cassarino, G.
    Arico, D.
    Ialuna, S.
    Miceli, A.
    Rizza, E.
    Ferrari, C.
    Travascio, L.
    Marongiu, A.
    Garrou, F.
    Paccagnella, A.
    De Rimini, M.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2024, 51 : S19 - S20
  • [4] Prognostic impact of 18F-FDG PET/CT staging and of pathological response to neoadjuvant chemotherapy in triple-negative breast cancer
    D. Groheux
    S. Giacchetti
    M. Delord
    A. de Roquancourt
    P. Merlet
    A. S. Hamy
    M. Espié
    E. Hindié
    European Journal of Nuclear Medicine and Molecular Imaging, 2015, 42 : 377 - 385
  • [5] Prognostic impact of 18F-FDG PET/CT staging and of pathological response to neoadjuvant chemotherapy in triple-negative breast cancer
    Groheux, D.
    Giacchetti, S.
    Delord, M.
    de Roquancourt, A.
    Merlet, P.
    Hamy, A. S.
    Espie, M.
    Hindie, E.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2015, 42 (03) : 377 - 385
  • [6] 18F-FDG PET/CT for the Early Evaluation of Response to Neoadjuvant Treatment in Triple-Negative Breast Cancer: Influence of the Chemotherapy Regimen
    Groheux, David
    Biard, Lucie
    Giacchetti, Sylvie
    Teixeira, Luis
    Hindie, Elif
    Cuvier, Caroline
    Vercellino, Laetitia
    Merlet, Pascal
    de Roquancourt, Anne
    de Cremoux, Patricia
    Resche-Rigon, Matthieu
    Espie, Marc
    JOURNAL OF NUCLEAR MEDICINE, 2016, 57 (04) : 536 - 543
  • [7] Head-to-Head Comparison of [18F]PSMA-1007 and [18F]FDG PET/CT in Patients with Triple-Negative Breast Cancer
    Andryszak, Natalia
    Swiniuch, Daria
    Wojcik, Elzbieta
    Ramlau, Rodryg
    Ruchala, Marek
    Czepczynski, Rafal
    CANCERS, 2024, 16 (03)
  • [8] Head-to-Head Comparison of [18F]PSMA-1007 and [18F] FDG PET/CT in Patients with Triple-Negative Breast Cancer
    Andryszak, N.
    Swiniuch, D.
    Wojcik, E.
    Ramlau, R.
    Ruchala, M.
    Czepczynski, R.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2024, 51 : S18 - S19
  • [9] Now Is the Time to Use 18F-FDG PET/CT to Optimize Neoadjuvant Treatment in Triple-Negative Breast Cancer!
    Groheux, David
    JOURNAL OF NUCLEAR MEDICINE, 2018, 59 (06) : 863 - 864
  • [10] Identification of Biomarkers Including 18FDG-PET/CT for Early Prediction of Response to Neoadjuvant Chemotherapy in Triple-Negative Breast Cancer
    Humbert, Olivier
    Riedinger, Jean-Marc
    Charon-Barra, Celine
    Berriolo-Riedinger, Alina
    Desmoulins, Isabelle
    Lorgis, Veronique
    Kanoun, Salim
    Coutant, Charles
    Fumoleau, Pierre
    Cochet, Alexandre
    Brunotte, Francois
    CLINICAL CANCER RESEARCH, 2015, 21 (24) : 5460 - 5468
12345